Cannara Biotech (OTCMKTS:CNBTF) Stock Price Down 1% – What’s Next?

Cannara Biotech (OTCMKTS:CNBTF) shares were down 1% during mid-day trading on Tuesday . The stock traded as low as $1.23 and last traded at $1.24. Approximately 10,275 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 33,127 shares. The stock had previously closed at $1.2520.

Cannara Biotech Price Performance

The company’s 50-day moving average is $1.31 and its 200-day moving average is $1.29.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.